
Cintodac Capsule
Salt Composition: Cinitapride (3mg) + Pantoprazole (40mg)
Expiry Date: 01/2028
Inclusive of all taxes
10 Capsule
About The Product
Used For Gerd, Acidity, And Bloating
Description
Cintodac capsule is a combination of medicine used in the treatment of Gerd, Acidity, And Bloating. The medicine contains two active drug Cinitapride in 3mg which helps improve gastrointestinal motility and Pantoprazole in 40mg, a proton pump inhibitor that reduces stomach acid production.
The combination helps improve symptoms such as heartburn, acid reflux and abdominal discomfort. The medicine exact dosage and duration is recommended by the healthcare professional.
Uses
- Uesd Gerd, acidity and bloating
Side Effects
Cinitapride 3mg capsule cause certain side effects. However, some patients may experience severe symptoms and some experience mild symptoms. It depends on the patient's body how it responds. Consult the healthcare professional if any of the symptoms persist:
- Headache
- Diarrhea
- Stomach pain
- Flatulence
- Dizziness
- Chest pain
- Constipation
- Itching
- Loose and watery stools
- Gas or fart
How To Use
- Pantoprazole in 40mg capsule should be taken 30-40 minutes before food as advised by the healthcare professional. Follow the exact recommendation on the dosage and timings to ensure safe and effective treatment option.
- Swallow the whole glass of water without chewing or crushing the capsule. The medication should be taken under doctor strict guidance to avoid side effects and ensure proper management of the condition.
How It Works
- The lower esophageal sphincter (LES), muscle weakens or relaxes too often, allowing acid to escape and cause GERD and bloating. These three are interconnected digestive issues where stomach acids flows back into the esophagus, leading to burning.
- Cintodac capsule contains proton pump inhibitor (PPi) powerful inhibitor that significantly reduce stomach acid by blocking the final step of acid production.
Safety Advice
Alcohol is strictly prohibited while using Cintodac capsule. Consult the health care professional before using the medication.
Pregnant women should avoid using Cintodac capsule as it contains two drugs which can be harm the developing fetus in mother's womb. Consult the doctor for proper medical assistance.
Cintodac capsule has not been taken by breastfeed women as it contains high concentration of two drugs that passes from breast which harm the baby. For more information consult the doctor.
Cintodac capsule may cause dizziness, if you experience fainting and lightheadedness should avoid driving or operating machinery and sit and lie down until the feeling passes.
Kidney patients should avoid using Cintodac capsule may affect the kidney function and making it hard to treat both the disease.
Cintodac capsule interrupt with the liver function. If you have pre-existing liver conditions or notice symptoms such as yellowing of skin or eyes (jaundice) should inform the doctor Immedietly. Regular monitoring should be required while taking this medication to ensure safety and effectiveness.
FAQs
- Follow the prescription as recommended by the healthcare professional
- Monitor the side effects to ensure safety and effectivenss.
- Swallow the whole tablet without chewing or crushing it.
- Avoid driving or dizziness while taking the emdication
References
- Macharla, S., & Bairam, R. (2018). Analytical method development and validation for simultaneous estimation of cinitapride hydrogen tartrate and pantoprazole sodium in pharmaceutical dosage form by RP-HPLC. Der. Pharma. Chemica, 10, 1123-1128. https://www.derpharmachemica.com/pharma-chemica/analytical-method-development-and-validation-for-simultaneous-estimation-of-cinitapride-hydrogen-tartrate-and-pantoprazole-sodium-15273.html
- Vidyadhara, S., Rao, Y. S., Ramu, A., Sasidhar, R. L., & Ramya, A. J. (2013). Method development and validation for the simultaneous estimation of cinitapride and pantoprazole in solid dosage forms by RP-HPLC. Oriental Journal of Chemistry, 29(3), 1213. https://www.orientjchem.org/vol29no3/method-development-and-validation-for-the-simultaneous-estimation-of-cinitapride-and-pantoprazole-in-solid-dosage-forms-by-rp-hplc/
- Bhuva, S. D., & Patel, M. M. (2012). Spectrophotometric simultaneous estimation of omeprazole and cinitapride in bulk and formulation. Asian Journal of Pharmaceutical and Clinical Research, 5(4), 40-42.
- Shivakrishna, N., Jahnavi, N. S., Marella, P., Krishna, G. P. R., Kumar, V. D. S., & Rao, P. V. Pharmaceutical and Nano Sciences.
- Mathew, M., Madathil, S., Govind, A., & Swamy, V. B. (2016). Formulation and Evaluation of Cinitapride Controlled Release Tablets. Asian Journal of Pharmaceutical Research, 6(2), 87-94.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
